{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-24-002393","form_type":"8-K","ticker":"ENTXW","cik":"0001638097","company_name":"Entera Bio Ltd.","filed_at":"2024-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.905316+00:00","generated_at":"2026-05-31T13:28:31.360289+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Entera Bio shareholders approve all 8 proposals at 2024 annual meeting","bullets":["Elected Miranda Toledano and Yonatan Malca to three-year board terms with ~99% of votes cast.","Approved one-time CEO compensation grant for Miranda Toledano (14,365,894 for, 544,357 against).","Approved amendment to 2018 Equity Incentive Plan, increasing shares by 1,788,515 (14,131,640 for).","Ratified Kesselman & Kesselman (PwC) as independent auditors for FY2024 with overwhelming support.","Advisory vote on executive compensation passed; the most frequent frequency vote was 'one year'."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-24-002393","json":"https://secwatch.observer/filing/0001178913-24-002393.json","markdown":"https://secwatch.observer/filing/0001178913-24-002393.md","text":"https://secwatch.observer/filing/0001178913-24-002393.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638097/000117891324002393/0001178913-24-002393-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638097/000117891324002393/zk2431764.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:28:31.360289+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}